{"title":"Liraglutide: a new option in the management of type 2 diabetes","authors":"Milan K Piya, Abd A Tahrani, Anthony H Barnett","doi":"10.1002/fps.10","DOIUrl":null,"url":null,"abstract":"<p>Type 2 diabetes mellitus (T2DM) is a global epidemic with an expected prevalence of 380 million in 2025 worldwide<sup>1</sup> and over 2.5 million by 2010 in the UK.<sup>2</sup> Diabetes is a progres-sive disease which leads to macro and microvascular complications and reduced life expectancy.<sup>2</sup> Furthermore, diabetes-related complications have been shown to worsen patients' quality of life.<sup>3,4</sup> Copyright © 2008 John Wiley & Sons, Ltd.</p>","PeriodicalId":100566,"journal":{"name":"Future Prescriber","volume":"9 2","pages":"6-12"},"PeriodicalIF":0.0000,"publicationDate":"2008-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/fps.10","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future Prescriber","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/fps.10","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3
Abstract
Type 2 diabetes mellitus (T2DM) is a global epidemic with an expected prevalence of 380 million in 2025 worldwide1 and over 2.5 million by 2010 in the UK.2 Diabetes is a progres-sive disease which leads to macro and microvascular complications and reduced life expectancy.2 Furthermore, diabetes-related complications have been shown to worsen patients' quality of life.3,4 Copyright © 2008 John Wiley & Sons, Ltd.
利拉鲁肽:治疗2型糖尿病的新选择
2型糖尿病(T2DM)是一种全球性流行病，预计到2025年全球患病率将达到3.8亿1，到2010年英国将超过250万2糖尿病是一种进行性疾病，可导致大血管和微血管并发症，降低预期寿命2此外，糖尿病相关的并发症已被证明会使患者的生活质量恶化。版权所有©2008 John Wiley &儿子,有限公司
本文章由计算机程序翻译，如有差异，请以英文原文为准。
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
